📰 Juergen Eckhardt News
Juergen Eckhardt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Juergen Eckhardt. Real-time updates on events, politics, business and more.
April 30, 2024
Bayer and Evotec Collaborate to Advance Precision Cardiology
April 30, 2024
Bayer and Evotec have announced an expansion of their strategic collaboration towards innovative precision therapies for cardiovascular disease .The collaboration aims to identify and validate new...
April 30, 2024
EQS-News: Evotec SE / Key word: Miscellaneous Bayer and Evotec collaborate to advance precision cardiology 30.04.2024 / 08:30 CET/CEST The issuer is solely responsible...
February 13, 2024
The funding will advance two precision TYK2 inhibitors into the clinic for multiple sclerosis, psoriasis and other severe autoimmune and neurologic conditions.New investors include Dementia Discovery Fund, Leaps by Bayer, and UPMC Enterprises.CARMEL, Ind.--(BUSINESS WIRE)--#TYK2--Sudo Biosciences (“Sudo”), a biophar...
January 8, 2024
Bayer and RTW Investments lead Series D financing in Chinese biotech Ji Xing Pharmaceuticals
January 8, 2024
Germany - Bayer and RTW Investments, LP today announced an equity investment into Ji Xing Pharmaceuticals Limited in the amount of USD 35 million and USD 127 million respectively. JIXING, founded...
November 12, 2023
Berlin: Bayer AG has announced the global expansion of its life science incubator network, Bayer Co.Lab, to Shanghai, China, and Kobe, Japan.This move establishes new sites for the Bayer Co.Lab...
October 5, 2023
EQS-News: Evotec SE / Key word(s): MiscellaneousEvotec, ClavystBio, Leaps by Bayer, Lightstone Ventures and Polaris Partners launch '65LAB' 05.10.2023 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.  A UNIQUE COMPANY CREATION VEHICLE INITIATED BY LIGHTSTONE VENTURE...
October 5, 2023
A unique company creation vehicle initiated by Lightstone Ventures and Evotec SE, and established with partners ClavystBio, Leaps by Bayer, Polaris Partners,...